Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.coviro.2014.09.006 http://scihub22266oqcxt.onion/10.1016/j.coviro.2014.09.006 C4570620!4570620 !25285614     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=25285614 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Curr+Opin+Virol 2014 ; 9 (?): 53-60 Nephropedia Template TP {{tp|p=25285614 |t=2014. Roseoloviruses in transplant recipients: clinical consequences and prospects for treatment and prevention trials |pdf=|usr=}}{{25285614 }} gab.com Text Roseoloviruses in transplant recipients: clinical consequences and prospects for treatment and prevention trials JO: Curr Opin Virol http://www.kidney.de/pget.php?&tw=1&pmid=25285614 #FOAvip Roseoloviruses frequently reactivate in transplant recipients. We review the impact of Roseoloviruses in transplant recipients and highlight research priorities. Human herpesvirus 6A (HHV-6A) and HHV-6B were recently classified as distinct species with important differences. Both viruses can result in inherited chromosomally integrated HHV-6, which may cause complications after transplant. HHV-6B is the primary species associated with disease and appears to have pleiotropic effects on the central nervous system. Small preemptive and prophylactic studies have not shown a statistically significant impact on HHV-6 disease. Although Roseoloviruses are associated with diverse complications in transplant patients, studies providing strong evidence for a causal role are lacking. Trials focusing on prevention and treatment will be important to inform the significance of Roseolovirus reactivation. Twit Text FOAVip Roseoloviruses in transplant recipients: clinical consequences and prospects for treatment and prevention trials ????Curr Opin Virol http://www.kidney.de/pget.php?&tw=1&pmid=25285614 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25285614 #FOAvip English Wikipedia <ref>{{Cite pmid|25285614 }}</ref> Roseoloviruses in transplant recipients: clinical consequences and prospects for treatment and prevention trials #MMPMID25285614 Hill JA ; Zerr DM Curr Opin Virol 2014[Dec]; 9 (?): 53-60 PMID25285614 show ga Roseoloviruses frequently reactivate in transplant recipients. We review the impact of Roseoloviruses in transplant recipients and highlight research priorities. Human herpesvirus 6A (HHV-6A) and HHV-6B were recently classified as distinct species with important differences. Both viruses can result in inherited chromosomally integrated HHV-6, which may cause complications after transplant. HHV-6B is the primary species associated with disease and appears to have pleiotropic effects on the central nervous system. Small preemptive and prophylactic studies have not shown a statistically significant impact on HHV-6 disease. Although Roseoloviruses are associated with diverse complications in transplant patients, studies providing strong evidence for a causal role are lacking. Trials focusing on prevention and treatment will be important to inform the significance of Roseolovirus reactivation. |*Immunocompromised Host [MESH] |*Transplant Recipients [MESH] |Herpesvirus 6, Human/genetics/physiology [MESH] |Humans [MESH] |Roseolovirus Infections/*epidemiology/*pathology [MESH] |Virus Activation [MESH]Roseoloviruses in transplant recipients: clinical consequences and pro(epmc).pdf DeepDyve Pubget Overpricing